Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Operating Expenses: 2012-2019

Historic Operating Expenses for Larimar Therapeutics (LRMR) over the last 8 years, with Dec 2019 value amounting to $45.7 million.

  • Larimar Therapeutics' Operating Expenses fell 73.16% to $3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $35.9 million, marking a year-over-year decrease of 38.77%. This contributed to the annual value of $45.7 million for FY2019, which is 25.31% down from last year.
  • Per Larimar Therapeutics' latest filing, its Operating Expenses stood at $45.7 million for FY2019, which was down 25.31% from $61.1 million recorded in FY2018.
  • In the past 5 years, Larimar Therapeutics' Operating Expenses registered a high of $73.8 million during FY2015, and its lowest value of $45.7 million during FY2019.
  • In the last 3 years, Larimar Therapeutics' Operating Expenses had a median value of $53.0 million in 2017 and averaged $53.3 million.
  • Per our database at Business Quant, Larimar Therapeutics' Operating Expenses surged by 107.74% in 2015 and then dropped by 25.31% in 2019.
  • Larimar Therapeutics' Operating Expenses (Yearly) stood at $73.8 million in 2015, then dropped by 21.12% to $58.2 million in 2016, then decreased by 8.98% to $53.0 million in 2017, then rose by 15.33% to $61.1 million in 2018, then declined by 25.31% to $45.7 million in 2019.